In a recent interview with The New York Times, Oura Health CEO Tom Hale refrained from commenting on reports of new funding that could value the health-tracking ring maker at nearly $11 billion. However, he did express his thoughts on the potential for taking Oura public in the future.
Want More Context? 🔎
Oura CEO Discusses Potential IPO and Data Privacy
Please login to join discussion
News Summarized. Time Saved. Bite-sized news briefs for busy people. No fluff, just facts.